Wang Ruihua, Yang Liu, Jin Shui, Han Xingmin, Liu Baoping
1Department of Nuclear Medicine, The First Affiliated Hospital, College of Medicine, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou University, 1 Jianshe East Road, Zhengzhou, 450052 Henan China.
2Department of Nuclear Medicine, Zhejiang Cancer Hospital, Hangzhou, 310011 Zhejiang China.
Cancer Cell Int. 2018 Nov 19;18:189. doi: 10.1186/s12935-018-0686-9. eCollection 2018.
This study was to investigate the influence of thyroid stimulating hormone (TSH) suppression time on the cardiac function of differentiated thyroid carcinoma (DTC) patients.
105 DTC patients were divided into strict TSH suppression group (model group, TSH ≤ 0.1 mU/L) and general TSH suppression group (control group, TSH > 0.1 mU/L). According to the suppression time, these two groups were respectively divided into three groups: group within half a year, group between half a year and a year and group more than a year. Gated myocardial perfusion imaging was applied to observe differences of left ventricle (LV) myocardial perfusion, LV diastolic and systolic function and LV systolic synchrony in every group.
The left ventricular diastolic function, systolic synchrony and myocardial perfusion level of model group decreased with prolonged suppression time. The values of left ventricular EF, PFR and BPM in patients less than half a year were higher than those in 6 months to 1 year for control group.
Thyroid stimulating hormone suppression can influence the cardiac function of patients and with the prolongation of suppression time, regardless of the level of TSH suppression, the possibility of cardiac function depression in patients will increase. TSH may lower the risk of cardiovascular disease in high-risk patients than those in TSH patients with moderate or low risk. The drugs improving cardiac function should be used cooperatively in different suppression period to decrease the occurrence rate of cardiac adverse reactions.
本研究旨在探讨促甲状腺激素(TSH)抑制时间对分化型甲状腺癌(DTC)患者心功能的影响。
将105例DTC患者分为严格TSH抑制组(模型组,TSH≤0.1 mU/L)和一般TSH抑制组(对照组,TSH>0.1 mU/L)。根据抑制时间,将这两组分别分为三组:半年内组、半年至一年组和一年以上组。采用门控心肌灌注显像观察各组左心室(LV)心肌灌注、LV舒张和收缩功能以及LV收缩同步性的差异。
模型组左心室舒张功能、收缩同步性和心肌灌注水平随抑制时间延长而降低。对照组半年内患者的左心室EF、PFR和BPM值高于6个月至1年患者。
促甲状腺激素抑制可影响患者的心功能,且随着抑制时间的延长,无论TSH抑制水平如何,患者心功能抑制的可能性都会增加。与中低风险TSH患者相比,TSH可能会降低高危患者心血管疾病的风险。在不同抑制期应联合使用改善心功能的药物,以降低心脏不良反应的发生率。